Chronic aortic regurgitation
Encounter flow
12/12 authoredCanonical 12-phase frame with authored status for this dossier.
Frame
Confirm chronic AR; if acute severe AR (dissection/endocarditis) → emergency route cardio.aortic-dissection.core.v1 / IE engine
chronic AR confirmed
Patient inputs (11)
Surgical risk + bicuspid/syndromic aortopathy probability
Chronic (compensated dilated LV) vs acute (small non-compliant LV, shock) — acute routes out
VC/RF/EROA/flow-reversal → ACC/AHA stage
LVEF ≤55% in severe AR = Class I AVR (stage C2)
LVESD >50 mm (or >25 mm/m² indexed) = Class IIa AVR
Root/ascending diameter drives aortic replacement independent of valve
Symptomatic severe AR (stage D) = Class I AVR
HTN raises wall stress — BP control bridge (ACEi/ARB/DHP-CCB)
Contrast for CT aorta + peri-op risk
Marfan/Loeys-Dietz/vEDS lower aortic surgical threshold + ARB/BB therapy
Bicuspid aortopathy lower threshold + first-degree family screening
* = hard-required. Engine cannot meaningfully run until these are filled.
Severity triggers (9)
- informationallife_threateningacute_ar_emergencyAcute severe AR (endocarditis leaflet destruction or aortic dissection) — small non-compliant LV → shock/flash edema — EMERGENCY surgery — 2020 ACC/AHA VHDTrigger could not be auto-evaluated — needs clinician judgement.
- informationalsevereclass_I_avr_symptomaticSymptomatic severe chronic AR (stage D) — Class I surgical AVR — 2020 ACC/AHA VHDTrigger could not be auto-evaluated — needs clinician judgement.
- informationalsevereclass_I_avr_lv_dysfunctionAsymptomatic severe AR + LVEF ≤55% (stage C2) — Class I AVR — 2020 ACC/AHA VHDTrigger could not be auto-evaluated — needs clinician judgement.
- informationalseveresyndromic_aortopathy_branchMarfan / Loeys-Dietz / vascular EDS — ARB + BB, earlier aortic surgery (Marfan ≥4.5–5.0 cm; Loeys-Dietz lower), genetics + cascade — 2022 ACC/AHA AorticTrigger could not be auto-evaluated — needs clinician judgement.
- informationalseverepregnancy_special_popPregnancy/planning — STOP ACEi/ARB; use BB; mWHO risk by aortic root size (root >4.5 cm Marfan = very high risk / consider pre-pregnancy repair); cardio-obstetric — ESC 2018 PregnancyTrigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderatelvesd_threshold_IIaAsymptomatic severe AR + LVEF >55% + LVESD >50 mm (or >25 mm/m² indexed) — Class IIa AVR — 2020 ACC/AHA VHDTrigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderatebicuspid_aortopathy_branchBicuspid aortic valve with aortopathy — lower aortic surgical threshold (≥5.0 cm with risk features); first-degree family echo screening — 2022 ACC/AHA AorticTrigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderateckd_special_popCKD — minimise iodinated contrast for aortic CT (use MR), renal-adjust peri-op meds — KDIGO 2024Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderatelv_dysfunction_post_avrPersistent LV dysfunction after AVR — co-manage as HFrEF with GDMT — 2022 ACC/AHA HFTrigger could not be auto-evaluated — needs clinician judgement.
Workflow calculators
Run this disease's risk and dosing calculators inline.
Recommended regimen
Chronic AR — intervention timing + BP/aortopathy bridge (2020 ACC/AHA VHD; 2022 ACC/AHA Aortic)outpatient playbook — drug actions (2)
- 1. losartan ± amlodipine for BP/wall stresslosartan 50–100 mg • PO • dailytrigger: HTN with AR or aortopathy (2020 ACC/AHA VHD)Afterload + aortic-growth reduction
- 2. metoprolol if syndromic aortopathy25–100 mg • PO • BIDtrigger: Marfan/aortic dilatation (2022 ACC/AHA Aortic)Slows aortic dilatation; balance diastolic prolongation
Auto-drafted A&P note
outpatientSubjective
- Possible entry pathways: Early diastolic decrescendo murmur at LSB; Wide pulse pressure / bounding pulses; Echo: severe AR (VC >0.6 cm, RF ≥50%, EROA ≥0.30 cm², holodiastolic flow reversal).
Objective
- No vitals, labs, or imaging entered for this encounter.
Assessment
**Chronic aortic regurgitation** (cardio.aortic-regurgitation.chronic.v1). Phenotype framing: Chronic vs acute AR; valve-driven vs aortopathy-driven; mixed AS/AR Scope: Confirm chronic AR; if acute severe AR (dissection/endocarditis) → emergency route cardio.aortic-dissection.core.v1 / IE engine No severity triggers fired against current inputs.
Plan
Regimen axis: **Chronic AR — intervention timing + BP/aortopathy bridge (2020 ACC/AHA VHD; 2022 ACC/AHA Aortic)** — step "Stage B/C1 — asymptomatic, preserved LV, normal aorta — SURVEILLANCE". Setting playbook (outpatient) — Stage AR + aorta, control BP, refer for AVR/aortic surgery at the correct trigger, screen family (2020 ACC/AHA VHD; 2022 ACC/AHA Aortic) 1. losartan ± amlodipine for BP/wall stress losartan 50–100 mg PO daily — HTN with AR or aortopathy (2020 ACC/AHA VHD) (Afterload + aortic-growth reduction) 2. metoprolol if syndromic aortopathy 25–100 mg PO BID — Marfan/aortic dilatation (2022 ACC/AHA Aortic) (Slows aortic dilatation; balance diastolic prolongation) Non-pharmacologic actions: - Refer for surgical AVR ± aortic replacement when Class I/IIa or aortic threshold met — 2020 ACC/AHA VHD; 2022 Aortic - First-degree family echo screening for bicuspid valve/aortopathy — 2022 ACC/AHA Aortic - Endocarditis prophylaxis only if prior IE or prosthetic material — 2020 ACC/AHA VHD AVOID / contraindication checks: - No medical therapy delays surgery in symptomatic or LV decompensated severe AR — 2020 ACC/AHA VHD - Caution pure BB in severe AR diastolic prolongation increases regurgitation — 2020 ACC/AHA VHD - ACEi ARB contraindicated in pregnancy switch to BB — fetotoxic RAS blockade - Lower aortic surgical threshold in Marfan LoeysDietz bicuspid — 2022 ACC/AHA Aortic
Monitoring
Regimen monitoring: - TTE q6-12mo severe asymptomatic — 2020 ACC/AHA VHD - TTE q1-2yr moderate — 2020 ACC/AHA VHD - aortic imaging CT or MR by root size and growth rate — 2022 ACC/AHA Aortic - serial LVEF LVESD for intervention trigger — 2020 ACC/AHA VHD - first degree family screening bicuspid or syndromic — 2022 ACC/AHA Aortic Setting (outpatient) monitoring: - Serial TTE + aortic imaging per severity and root size — 2020 ACC/AHA VHD; 2022 Aortic - Symptom + BP review each visit — 2020 ACC/AHA VHD Follow-up plan: Family screening (bicuspid/syndromic); route to HFrEF engine if LV dysfunction - Close-out criterion: follow-up + screening + escalation triggers documented Monitoring phase: Serial TTE + aortic imaging by severity and root size
Disposition
Current setting: outpatient — Stage AR + aorta, control BP, refer for AVR/aortic surgery at the correct trigger, screen family (2020 ACC/AHA VHD; 2022 ACC/AHA Aortic) Disposition criteria: - Asymptomatic non-severe, normal aorta → routine surveillance - Class I/IIa or aortic threshold → AVR ± aortic surgery referral - Prohibitive surgical risk + pure AR → transcatheter AR device evaluation Escalation triggers (move to higher acuity): - Symptoms OR LVEF ≤55% OR LVESD >50 mm (>25 mm/m²) → surgical referral now — 2020 ACC/AHA VHD - Aortic root/ascending at threshold → aortic surgery — 2022 ACC/AHA Aortic - Acute severe AR (dissection/IE features) → ED + emergency route — 2020 ACC/AHA VHD
Earlier-Return Triggers
Return-precaution thresholds (watch for): - [LIFE_THREATENING] Acute severe AR (endocarditis leaflet destruction or aortic dissection) — small non-compliant LV → shock/flash edema — EMERGENCY surgery — 2020 ACC/AHA VHD - [SEVERE] Symptomatic severe chronic AR (stage D) — Class I surgical AVR — 2020 ACC/AHA VHD - [SEVERE] Asymptomatic severe AR + LVEF ≤55% (stage C2) — Class I AVR — 2020 ACC/AHA VHD
Citations
- 2020 ACC/AHA VHD Guideline + 2022 ACC/AHA Aortic Disease Guideline + 2021 ESC/EACTS VHD Guideline [PMID:33332149](https://pubmed.ncbi.nlm.nih.gov/33332149/) - Cited evidence (PMID 36322642) [PMID:36322642](https://pubmed.ncbi.nlm.nih.gov/36322642/) - Cited evidence (PMID 34453165) [PMID:34453165](https://pubmed.ncbi.nlm.nih.gov/34453165/) - Cited evidence (PMID 25409260) [PMID:25409260](https://pubmed.ncbi.nlm.nih.gov/25409260/) - Cited evidence (PMID 10199862) [PMID:10199862](https://pubmed.ncbi.nlm.nih.gov/10199862/) Last reconciled with current guidelines: 2026-05-16.
- 2020 ACC/AHA VHD Guideline + 2022 ACC/AHA Aortic Disease Guideline + 2021 ESC/EACTS VHD Guideline — PMID:33332149
- Cited evidence (PMID 36322642) — PMID:36322642
- Cited evidence (PMID 34453165) — PMID:34453165
- Cited evidence (PMID 25409260) — PMID:25409260
- Cited evidence (PMID 10199862) — PMID:10199862